Reimagining Global Commercialisation
20-21 October, Berlin, Germany
We are the global commercialisation partner reimagining how life sciences companies bring innovations to market – driven by data, human expertise, powered by AI, and committed to improving patient outcomes worldwide.
Request a meeting with one of our commercialisation experts to explore the next frontier of innovation in life sciences!
Engage in Expert-Led Sessions
Discover strategies to accelerate global access and patient impact.
The New Commercialization Imperative: Turning Innovation into Patient Impact [Plenary]
- Mike Ryan, President, Europe, EVERSANA
- Felipe Florez-Arango, CEO, Helvion Pharma
- Stefan Zillikens MSc, PhD, Cogent HealthCare GmbH
Death of a Salesman. The Birth of Omnideployment
- James May, Global Media Lead, EVERSANA
- Dan Feldman, SVP, Strategy & Development – UK, EU & APAC, EVERSANA
- Tim Rubesam, VP, Head of Global Marketing, Biotest
How Agentic AI Makes Behavioural Science Available to Everyone
- Harriet Painter, VP, MedComms, EVERSANA
- Michael Le Brocq, SVP, Head of Global Strategy, EVERSANA
- Alexane Gurwic, Independent Advisor, Digital Health & Customer Engagement
- Natasha Hansjee, Integrated Medical Engagement Catalyst, Roche Global Medical Affairs
The Rise of Digital-First Access Pathways in Europe
- Alberta Spreafico, SVP, Health Innovation, EVERSANA
- Nico Hribernik, Co-Founder and CEO, Wellster
- Martin Moller Paarse, CEO, Liva Healthcare
- Alan Crowther, General Manager, Global Pricing, Access and Digital Solutions, EVERSANA
Our Latest Insights on Key Industry Topics
EVERSANA Back as Frontiers Health Global Host & Presenting Sponsor
How IRA, MFN, and HTA are rewriting oncology launch strategy
One Year of EVERSANA’s AI Agency: What We Learned at Google’s New York Headquarters
Navigating the Intersection of AI, Global Commercialization and Patient Value